DrugPatentWatch Database Preview
Roche Palo Company Profile
What is the competitive landscape for ROCHE PALO, and what generic and branded alternatives to ROCHE PALO drugs are available?
Drugs and US Patents for Roche Palo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche Palo | TORADOL | ketorolac tromethamine | INJECTABLE;INJECTION | 019698-001 | Nov 30, 1989 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
Roche Palo | AEROBID | flunisolide | AEROSOL, METERED;INHALATION | 018340-001 | Aug 17, 1984 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
Roche Palo | TICLID | ticlopidine hydrochloride | TABLET;ORAL | 019979-001 | Mar 24, 1993 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
Roche Palo | CYTOVENE | ganciclovir sodium | INJECTABLE;INJECTION | 019661-001 | Jun 23, 1989 | AP | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Roche Palo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche Palo | CYTOVENE | ganciclovir | CAPSULE;ORAL | 020460-001 | Dec 22, 1994 | 4,355,032 | ➤ Try a Free Trial |
Roche Palo | CYTOVENE | ganciclovir | CAPSULE;ORAL | 020460-001 | Dec 22, 1994 | 4,423,050 | ➤ Try a Free Trial |
Roche Palo | CELLCEPT | mycophenolate mofetil | SUSPENSION;ORAL | 050759-001 | Oct 1, 1998 | 4,753,935 | ➤ Try a Free Trial |
Roche Palo | CYTOVENE | ganciclovir | CAPSULE;ORAL | 020460-001 | Dec 22, 1994 | 4,507,305 | ➤ Try a Free Trial |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for ROCHE PALO drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | For Oral Suspension | 200 mg/mL | ➤ Subscribe | 2011-03-25 |
Similar Applicant Names
Here is a list of applicants with similar names.